Title:
トファシチニブ口腔内崩壊錠
Document Type and Number:
Japanese Patent JP6507272
Kind Code:
B2
Abstract:
The present invention relates to Orally Disintegrating Tablets (ODT) of Tofacitinib and its pharmaceutically acceptable salts and the process to produce the ODT. The invention further relates to ODTs comprising Tofacitinib and its pharmaceutically acceptable salts, at least one sweetening agent, at least one disintegrant and optionally other excipients. The weight of the Orally Disintegrating tablets is 200 mg or less. The invention further relates to Orally Disintegrating Tablets of Tofacitinib Citrate.
Inventors:
Gupta, Saurabe
Faldesai, Saieshpie.
Kumar, NSK. Sencil
Satay, Milind Vinyac
Faldesai, Saieshpie.
Kumar, NSK. Sencil
Satay, Milind Vinyac
Application Number:
JP2017565982A
Publication Date:
April 24, 2019
Filing Date:
June 24, 2016
Export Citation:
Assignee:
Unichem Laboratories Limited
International Classes:
A61K31/519; A61K9/20; A61K47/12; A61K47/26; A61K47/32; A61K47/38
Domestic Patent References:
| JP2005511696A | ||||
| JP2014181234A |
Foreign References:
| WO2008120548A1 | ||||
| WO2015051738A1 | ||||
| WO2009151072A1 | ||||
| WO2009102038A1 |
Other References:
原島秀吉編,新薬剤学(改訂第3版),株式会社南江堂発行,2011年,p.376
岡田弘晃他監修,製剤の達人による製剤技術の伝承 上巻 経口投与製剤の製剤設計と製造法,株式会社じほう発行,2013年,p.273
岡田弘晃他監修,製剤の達人による製剤技術の伝承 上巻 経口投与製剤の製剤設計と製造法,株式会社じほう発行,2013年,p.273
Attorney, Agent or Firm:
Takeshi Ebe
Kazuo Asahi
Kazuo Asahi